Table 2.
Group | N | Treatment | Time of Tissue Sampling | |
---|---|---|---|---|
Chow | Injection (i.p.) | |||
A | 10 | - | - | baseline |
B | 10 | vehicle | PBS | at the end of treatment |
C | 15 | vehicle | IgG2a isotype control (150 µg/week) | at the end of treatment |
D | 15 | vehicle | m6 (150 µg/week) | at the end of treatment |
E | 15 | PQ912 (0.8 g/kg pellets) | IgG2a isotype control (150 µg/week) | at the end of treatment |
F | 15 + 1 | PQ912 (0.8 g/kg pellets) | m6 (150 µg/week) | at the end of treatment |